Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00884039 · ClinicalTrials.gov registry record · NA
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients
A NA study, sponsored by Cornea Research Foundation of America.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00884039: Clinical Trial NA study, sponsored by Cornea Research Foundation of America.
NCT00884039 is a NA study that was terminated before completion, run by Cornea Research Foundation of America. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00884039, a NA study, was terminated before completion, sponsored by Cornea Research Foundation of America.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will investigate the use of anecortave acetate injection to reduce intraocular pressure (IOP) in corneal transplant recipients who are experiencing steroid-associated pressure control problems. Alternative methods of IOP control have been shown to entail serious risks. For example, reduction of topical steroids increases the risk of graft rejection, and use of glaucoma medications or glaucoma surgery increases the risk of graft failure. This study is designed to have sufficient power to detect whether a single injection can induce a clinically significant IOP reduction.
Primary Outcome
Intraocular pressure was measured by Goldmann applanation tonometry.
Interventions
- DRUG anecortave acetate
- DRUG 30 mg anecortave acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-09 |
| Phase | NA |
Why NCT00884039 stopped before completion
NCT00884039 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which anecortave acetate is the first listed.
NCT00884039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00884039 about?
NCT00884039 is a clinical study titled "Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients". This study will investigate the use of anecortave acetate injection to reduce intraocular pressure (IOP) in corneal transplant recipients who are experiencing steroid-associated pressure control problems. Alternative methods of IOP control have been shown to entail serious risks. For example, reduct...
What is the current status of trial NCT00884039?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2009-05. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00884039?
The interventions under investigation include: anecortave acetate (DRUG), 30 mg anecortave acetate (DRUG).
Who is sponsoring clinical trial NCT00884039?
This trial is sponsored by Cornea Research Foundation of America, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00884039's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia